LBRX
LB PHARMACEUTICALS INC
Latest close $44.93 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 5 parsed filing(s) · 2 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 29, 2026 filed · 29d Schedule 13G amendment | Reported accumulation | 1.8M +518.8K | 12.00% 0.00 pts | $32.46 | $39.00 | $44.93 |
| JPMorgan Chase / Asset Management CIK0000019617 | Jun 30, 2026 observed Jul 16, 2026 filed · 16d Initial Schedule 13G | Initial Schedule 13G | 1.5M +69.7K | 12.00% 0.00 pts | $32.46 | $30.59 | $44.93 |
| JPMorgan Chase / Asset Management CIK0000019617 | Mar 31, 2026 observed May 13, 2026 filed · 43d Schedule 13G amendment | Reported reduction | 1.4M -183.9K | 12.00% 0.00 pts | $24.66 | $32.31 | $44.93 |